Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden

  • H. Strömdahl
  • J. Tham
  • E. Melander
  • M. Walder
  • P. J. Edquist
  • I. Odenholt


The aim of this study was to investigate the prevalence of extended-spectrum beta-lactamase (ESBL)-producing bacteria in patients at various hospital wards and in a group of relatively healthy volunteers, in order to obtain greater knowledge on how common these bacterial strains are in hospital settings and in the general community. Participants (n = 427) were enrolled at a University Hospital and at Primary Health Care Units (PHCUs) in Sweden in 2008 and 2010. The participants provided rectal swabs, which were tested for the occurrence of ESBL-producing bacteria. Positive samples were analysed with polymerase chain reaction (PCR) methods for bacterial strain typing and ESBL phylogroups. In 2008, the prevalence was 2.1% (2/96) in PHCU subjects and 1.8% (2/113) in hospital patients. In 2010, the prevalence was 3.0% (3/100) in PHCU subjects and 6.8% (8/118) in hospital patients. The dominating phylogroups were CTX-M-1 and CTX-M-9. All ESBL-positive isolates were Escherichia coli. We found a higher prevalence of ESBL faecal carriage than expected, both in the hospital setting and in the PHCU group.


AmpC Primary Health Care Unit TaqMan Polymerase Chain Reaction Faecal Carriage Bacterial Strain Typing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We wish to acknowledge the assistance of the following individuals: Bodil Ekblad, Lisbeth Elfström and Agneta Hamberg, laboratory technicians, Medical Microbiology, Department of Laboratory Medicine, Malmö, Lund University, Sweden; Charlotta Hagstam, Mikael Karlsson and Håkan Sjöholm, PHCUs Anderslöv, Sjöbo and Eden Malmö, Sweden; Karin Tegmark Wisell, Unit for Antibiotics and Infection Control, Swedish Institute for Communicable Disease Control, Solna, Sweden.

Declaration of interest

None to declare.


  1. 1.
    Kahlmeter G (2008) Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints. Clin Microbiol Infect 14(Suppl 1):169–174PubMedCrossRefGoogle Scholar
  2. 2.
    Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18(4):657–686PubMedCrossRefGoogle Scholar
  3. 3.
    Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8(3):159–166PubMedCrossRefGoogle Scholar
  4. 4.
    European Antimicrobial Resistance Surveillance System (EARSS) (2010) Home page at: Accessed 16 April 2010
  5. 5.
    Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E (2010) Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea. Scand J Infect Dis 42(4):275–280PubMedCrossRefGoogle Scholar
  6. 6.
    Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32(8):1162–1171PubMedCrossRefGoogle Scholar
  7. 7.
    Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A (2008) Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 62(5):1142–1149PubMedCrossRefGoogle Scholar
  8. 8.
    Molstad S, Cars O, Struwe J (2008) Strama—a Swedish working model for containment of antibiotic resistance. Euro Surveill 13(46). pii: 19041Google Scholar
  9. 9.
    Swedish Institute for Infectious Disease Control (2010) Extended spectrum beta-lactamase (ESBL). Available online at: Accessed 25 October 2010
  10. 10.
    Kahlmeter G. The Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on methodology (SRGA-M). SRGA’s methodsGoogle Scholar
  11. 11.
    Wollin HH (2002) Infektionsdiagnostik 1:2: Infektioner i mag- och tarmkanalen. Smittskyddsinstitutet, Sweden, p 282Google Scholar
  12. 12.
    Melhus A (1996) Juhlin’s medium, a selective and differential medium for gram-negative rods. Med Microbiol Lett 5:74–81Google Scholar
  13. 13.
    Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, Steward C, Hill B, Medeiros AA, Tenover FC (1997) Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 41(3):647–653PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • H. Strömdahl
    • 1
  • J. Tham
    • 1
    • 5
  • E. Melander
    • 2
    • 3
  • M. Walder
    • 2
  • P. J. Edquist
    • 4
  • I. Odenholt
    • 1
  1. 1.Infectious Diseases Unit, Department of Clinical SciencesLund UniversityMalmöSweden
  2. 2.Medical Microbiology, Department of Laboratory MedicineLund UniversityMalmöSweden
  3. 3.Department of Infection Control, Laboratory MedicineSkåne CountySweden
  4. 4.Unit for Antibiotics and Infection ControlSwedish Institute for Communicable Disease ControlSolnaSweden
  5. 5.Infectious Diseases Unit, MalmöSkåne University HospitalMalmöSweden

Personalised recommendations